By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teva Pharmaceutical Industries Limited 

5 Basel Street

Petach Tikva    49131  Israel
Phone: 972-3-9267-267 Fax: 972-3-9234-050


Teva Pharmaceutical Industries Ltd. develops, produces and markets ethical drugs, generic drugs, and fine chemicals for the pharmaceutical industry and disposable products for hospitals and home care services.




Founders: Chaim Salomon, Moshe Levin, and Yitschak Elstein

CEO: Erez Vigodman

CEO Global Operations: Carlo de Notaristefani

CEO Global Specialty Medicines: Rob Koremans

CEO Global Generic Medicines: Sigudur (Siggi) Olafsson

CFO: Eyal Desheh

CMO (Medical):

CSO (Scientific): Michael Hayden


Please click here for Teva Pharma job opportunities.


Please click here for clinical trial information.


All Products

Key Statistics

Ownership: Public

Web Site: Teva
Employees: 5,700
Symbol: TEVA


Company News
Teva (TEVA) Release: Company Receives FDA Approval For VANTRELATM ER (Hydrocodone Bitartrate) Extended-Release Tablets [CII] Formulated With Proprietary Abuse Deterrence Technology 1/18/2017 7:38:51 AM
Teva (TEVA) Announces Completion Of Sale Of UK And Ireland Actavis (ACT) Assets And Operations Following European Commission Approval 1/9/2017 1:01:31 PM
Teva (TEVA) Settles Foreign Corruption Probe for $519 Million 12/27/2016 7:15:43 AM
Teva (TEVA) Reaches Settlement With Government On FCPA 12/22/2016 10:56:44 AM
Antares Pharma (ATRS) Announces The Successful Completion Of Teva (TEVA)’s Decentralized Procedure For Teriparatide Injection In Europe 12/19/2016 12:54:30 PM
20 U.S. States Sue Mylan (MYL), Teva (TEVA), and Others for Price Fixing 12/16/2016 6:36:22 AM
Teva (TEVA) Appoints Dipankar Bhattacharjee As President And Chief Executive Officer, Global Generic Medicines Group, Succeeding Siggi Olafsson 12/6/2016 12:03:09 PM
Teva (TEVA) Receives Positive Outcome For COPAXONE Label In Europe 12/6/2016 10:56:43 AM
Actavis (ACT) to Slash 200 Workers as Part of Teva (TEVA)'s Consolidation Efforts 11/29/2016 6:41:08 AM
Teva (TEVA) Secures European Approval Of Trisenox For First Line Treatment Of Low To Intermediate Risk Acute Promyelocytic Leukemia (APL) 11/21/2016 11:52:53 AM